Accel Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,459
Closed -$213K 310
2026
Q1
$213K Buy
2,459
+17
+0.7% +$1.63K 0.06% 265
2025
Q4
$235K Sell
2,442
-5
-0.2% -$486 0.06% 244
2025
Q3
$233K Sell
2,447
-123
-5% -$11.3K 0.07% 241
2025
Q2
$224K Buy
+2,570
New +$218K 0.07% 231
2023
Q2
Sell
-970
Closed -$78.2K 578
2023
Q1
$78.2K Sell
970
-128
-12% -$10.4K 0.03% 380
2022
Q4
$85.3K Buy
1,098
+58
+6% +$4.7K 0.04% 267
2022
Q3
$88K Buy
1,040
+4
+0.4% +$359 0.05% 266
2022
Q2
$92K Buy
1,036
+2
+0.2% +$203 0.05% 250
2022
Q1
$116K Sell
1,034
-73
-7% -$7.71K 0.06% 236
2021
Q4
$114K Buy
1,107
+3
+0.3% +$347 0.06% 241
2021
Q3
$138K Buy
1,104
+3
+0.3% +$388 0.09% 178
2021
Q2
$137K Buy
1,101
+277
+34% +$34.8K 0.09% 195
2021
Q1
$97K Buy
824
+1
+0.1% +$117 0.08% 221
2020
Q4
$96K Buy
+823
New +$90.6K 0.09% 209

Other funds holding MDT

Accel Wealth Management's MDT Position: Q2 2026 in Review

Accel Wealth Management sold out of Medtronic (MDT) in Q2 2026, closing a stake of 2,459 shares — an estimated $213K sold.

Accel Wealth Management first reported a position in MDT in Q4 2020 and held it in 14 quarters. The position peaked at $235K in Q4 2025. 606 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Accel Wealth Management reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Accel Wealth Management sold 2,459 Medtronic shares in Q2 2026, an estimated $213K.
  • Accel Wealth Management first reported a position in Medtronic in Q4 2020 and held it in 14 quarters.
  • Accel Wealth Management's Medtronic position peaked at $235K in Q4 2025.
  • 606 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Accel Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.